Stefan Oschmann

Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Stämm Biotech designs novel bio production system that leverages microfluidics and electroporation. It helps to solve the main constraint of the biotech industries. The company was founded by Federico D'Alvia Vegh and Juan Francisco Llamazares Vegh in 2014 and is headquartered in San Francisco, CA.

Stämm Biotech designs novel bio production system that leverages microfluidics and electroporation. It helps to solve the main constraint of the biotech industries. The company was founded by Federico D'Alvia Vegh and Juan Francisco Llamazares Vegh in 2014 and is headquartered in San Francisco, CA.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Malteser Deutschland gGmbH engages in the management and operation of medical and nursing care institutions. These include hospitals, senior homes, nursing facilities, and stationary hospices. The company was founded on May 3, 1999 and is headquartered in Cologne, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Malteser Deutschland gGmbH engages in the management and operation of medical and nursing care institutions. These include hospitals, senior homes, nursing facilities, and stationary hospices. The company was founded on May 3, 1999 and is headquartered in Cologne, Germany.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.